Geron reported $-3.64M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Amgen USD 2.38B 556M Jun/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Cassava Sciences USD -10.33M 2.21M Mar/2026
Cytokinetics USD -198.76M 7.27M Jun/2026
Exelixis USD 210.47M 34.06M Mar/2026
Genmab DKK 303M 250M Jun/2026
Geron USD -3.64M 27.5M Mar/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
Incyte USD 585.6M 282.27M Jun/2026
MacroGenics USD -36.77M 22.62M Mar/2026
Novartis USD 3.26B 108M Jun/2026
Novavax USD 17.53M 219.91M Dec/2025